Avg Loss
22.5%
Trial
72wk
Frequency
Weekly
FDA
Approved
Tirzepatide is the FDA-approved dual-agonist (GLP-1 + GIP) that demonstrated 22.5% average weight loss in the SURMOUNT-1 trial over 72 weeks. The GIP component reduces nausea relative to pure GLP-1 drugs, which is the main reason it tends to be better tolerated than equivalent-dose semaglutide. In the Philippines, branded Mounjaro is at international hospitals; research-grade tirzepatide is widely available from peptide suppliers.
A-01
Extensive safety data
FDA-approved with large Phase 3 SURMOUNT trials involving thousands of participants. Most well-studied weight loss peptide available.
A-02
Excellent tolerability
GIP component reduces nausea significantly compared to GLP-1-only drugs. Better tolerated than equivalent-dose semaglutide for most users.
A-03
Proven results
22.5% average weight loss in SURMOUNT-1. 87% of participants achieved at least 5% weight loss. Real-world results match trials.
Tirzepatide is the compound most readers of this site actually run, and the peso figure is the reason. Our partner and supplier lists tirzepatide 15mg at PHP 2,100, or PHP 1,890 with the standing 10% off. Buy tirzepatide in the Philippines
| Phase | Dose | Duration | Expected effect |
|---|---|---|---|
| Starting | 2.5mg | Weeks 1–4 | Tolerance building, mild appetite changes |
| Titration 1 | 5mg | Weeks 5–8 | Clear appetite suppression, first weight loss |
| Titration 2 | 7.5mg | Weeks 9–12 | Accelerated fat loss |
| Titration 3 | 10mg | Weeks 13–16 | Near maximum therapeutic effect |
| Target | 10–15mg | Ongoing | Maintenance and continued loss |
Generic research tirzepatide may be dosed differently than pharmaceutical Mounjaro pens. Verify mg per unit with your supplier.
2.5mg
Subtle appetite changes. Some users notice less interest in food. Minimal weight loss, primarily a tolerance-building phase.
5–7.5mg
Clear, noticeable appetite suppression. Food intake drops naturally. Weight loss becomes consistent: typically 0.5–1.5kg per week.
10–15mg
Maximum weight loss phase. Many users describe near-complete suppression of hunger. Rapid body composition changes. 10–20% total loss achievable.
Long-term
Weight loss slows as body weight decreases (fewer calories to cut). Maintenance becomes the goal. Many users stay at 10mg long-term.
↗ Related Filings
Our partner and supplier
Primara Labs, our partner and supplier, lists tirzepatide 15mg at PHP 2,100 a vial, PHP 1,890 with the standing 10% off, as a research vial shipped from stock already inside the Philippines. Mounjaro and Zepbound are prescription medicines and prescribing belongs with a licensed Philippine physician. Metro Manila is same day, the rest of the country one to three business days.
Buy tirzepatide in the Philippines